XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Plans and Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Option Activity under Stock-Based Compensation Plans

The following table summarizes the activity of stock options for the three months ended March 31, 2023:

 

 

 

Shares
Underlying
Outstanding
Options
(in thousands)

 

 

Weighted-
Average
Exercise
Price Per Share

 

 

Weighted-
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value (in thousands)

 

Balance as of December 31, 2022

 

 

9,339

 

 

$

10.70

 

 

4.61

 

 

$

16,291

 

Options granted

 

 

1,663

 

 

 

11.10

 

 

 

 

 

 

Options exercised

 

 

(41

)

 

 

5.84

 

 

 

 

 

 

 

Options cancelled:

 

 

 

 

 

 

 

 

 

 

 

 

Options forfeited (unvested)

 

 

(29

)

 

 

10.16

 

 

 

 

 

 

Options expired (vested)

 

 

(197

)

 

 

22.83

 

 

 

 

 

 

Balance as of March 31, 2023

 

 

10,735

 

 

$

10.56

 

 

 

4.84

 

 

$

11,820

 

Vested and expected to vest as of March 31, 2023

 

 

10,435

 

 

$

10.53

 

 

 

4.79

 

 

$

11,808

 

Exercisable as of March 31 2023

 

 

6,281

 

 

$

9.89

 

 

 

3.99

 

 

$

11,049

 

Summary of Restricted Stock Units Activity

The following table summarizes the activity of RSUs for the three months ended March 31, 2023:

 

 

 

Number of Shares
(in thousands)

 

 

Weighted-Average
Grant-Date Fair
Value Per Share

 

Non-vested as of December 31, 2022

 

 

3,479

 

 

$

11.00

 

Granted

 

 

2,152

 

 

 

11.06

 

Vested (1)

 

 

(1,236

)

 

 

10.12

 

Forfeited

 

 

(101

)

 

 

11.65

 

Non-vested as of March 31, 2023

 

 

4,294

 

 

$

11.27

 

Summary Of Performance Based Restricted Stock Unit

We granted market-based performance restricted stock units (“PSUs”) to certain executives. These PSUs vest upon a specified market condition. The summary of PSU activities for the three months ended March 31, 2023 is as follows:

 

 

 

Number of Shares
(in thousands)

 

 

Weighted-Average
Grant-Date Fair
Value Per Share

 

Non-vested as of December 31, 2022

 

 

193

 

 

$

11.62

 

Granted

 

 

364

 

 

 

18.25

 

Non-vested as of March 31, 2023

 

 

557

 

 

$

15.95

 

Fair Value-Based Measurements and Weighted-Average Assumptions The weighted-average assumptions used in the calculations of these fair value measurements are as follows:

 

 

 

Stock Options

 

 

 

Market-Based Performance Stock Units (“PSUs”)

 

 

 

Three Months Ended

 

 

 

Three Months Ended

 

 

March 31,

 

 

 

March 31,

 

 

2023

 

 

2022

 

 

 

2023

 

 

2022

 

Weighted-average fair value per share

 

$

7.28

 

 

$

8.05

 

 

 

$

18.25

 

 

$

11.62

 

Risk-free interest rate

 

 

4.0

%

 

 

1.9

%

 

 

 

4.3

%

 

 

1.7

%

Expected life (in years)

 

 

4.5

 

 

 

4.5

 

 

 

 

2.9

 

 

 

2.9

 

Volatility

 

 

0.8

 

 

 

0.8

 

 

 

 

0.9

 

 

 

0.9

 

Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense recorded in each component of operating expenses in our condensed consolidated statements of operations, and amounts capitalized to our inventories, net (in thousands):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2023

 

 

2022

 

 

Research and development

 

$

2,112

 

 

$

1,276

 

 

Selling, general and administrative

 

 

6,830

 

 

 

5,427

 

 

Cost of sales - product

 

 

695

 

 

 

160

 

 

Inventories, net

 

 

397

 

 

 

783

 

 

Total

 

$

10,034

 

 

$

7,646